全文获取类型
收费全文 | 7205篇 |
免费 | 498篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 61篇 |
儿科学 | 163篇 |
妇产科学 | 77篇 |
基础医学 | 1119篇 |
口腔科学 | 71篇 |
临床医学 | 841篇 |
内科学 | 1937篇 |
皮肤病学 | 131篇 |
神经病学 | 627篇 |
特种医学 | 241篇 |
外科学 | 1035篇 |
综合类 | 21篇 |
预防医学 | 532篇 |
眼科学 | 45篇 |
药学 | 382篇 |
中国医学 | 9篇 |
肿瘤学 | 448篇 |
出版年
2023年 | 31篇 |
2022年 | 48篇 |
2021年 | 190篇 |
2020年 | 102篇 |
2019年 | 175篇 |
2018年 | 195篇 |
2017年 | 118篇 |
2016年 | 129篇 |
2015年 | 192篇 |
2014年 | 265篇 |
2013年 | 329篇 |
2012年 | 540篇 |
2011年 | 521篇 |
2010年 | 313篇 |
2009年 | 278篇 |
2008年 | 476篇 |
2007年 | 479篇 |
2006年 | 468篇 |
2005年 | 474篇 |
2004年 | 451篇 |
2003年 | 447篇 |
2002年 | 422篇 |
2001年 | 85篇 |
2000年 | 88篇 |
1999年 | 115篇 |
1998年 | 109篇 |
1997年 | 62篇 |
1996年 | 56篇 |
1995年 | 58篇 |
1994年 | 52篇 |
1993年 | 23篇 |
1992年 | 41篇 |
1991年 | 42篇 |
1990年 | 49篇 |
1989年 | 42篇 |
1988年 | 40篇 |
1987年 | 33篇 |
1986年 | 24篇 |
1985年 | 16篇 |
1984年 | 17篇 |
1983年 | 10篇 |
1982年 | 12篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 12篇 |
1978年 | 8篇 |
1975年 | 8篇 |
1973年 | 11篇 |
1970年 | 11篇 |
1967年 | 7篇 |
排序方式: 共有7740条查询结果,搜索用时 15 毫秒
961.
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? 总被引:17,自引:0,他引:17 下载免费PDF全文
Adam R Azoulay D Castaing D Eshkenazy R Pascal G Hashizume K Samuel D Bismuth H 《Annals of surgery》2003,238(4):508-519
OBJECTIVE: To assess the viability of a strategy of primary resection with secondary liver transplantation (LT) for hepatocellular carcinoma (HCC) on cirrhosis. SUMMARY BACKGROUND DATA: LT is the optimal treatment of HCC with cirrhosis. Owing to organ shortage, liver resection is considered as a reasonable first-line treatment of patients with small HCC and good liver function, with secondary LT as a perspective in case of recurrence. The viability of such strategy, positively explored in theoretical models, is not documented in clinical practice. METHODS: Among 358 consecutive patients with HCC on cirrhosis treated by liver resection (n = 163; 98 of whom were transplantable) or transplantation (n = 195), the feasibility and outcome of secondary transplantation was evaluated in a 2-step fashion. First, secondary LT for tumor recurrence after resection (n = 17) was compared with primary LT (n = 195), to assess the risk and the outcome of secondary LT in patients who effectively succeeded to be treated by this approach. Second, primary resection in transplantable patients (n = 98) was compared with that of primary LT (n = 195) on an intention-to-treat basis, to assess the outcome of each treatment strategy and to determine the proportion of resected patients likely to be switched for secondary LT. Transplantability of resected patients was retrospectively determined according to selection criteria of LT for HCC. RESULTS: Operative mortality (< or =2 months) of secondary LT was significantly higher than that of primary LT (28.6% versus 2.1%; P = 0.0008) as was intraoperative bleeding (mean transfused blood units, 20.7 versus 10.5; P = 0.0001). Tumor recurrence occurred more frequently after secondary than after primary LT (54% versus 18%; P = 0.001). Posttransplant 5-year overall survival was 41% versus 61% (P = 0.03), and disease-free survival was 29% versus 58% (P = 0.003) for secondary and primary LT, respectively.Of 98 patients treated by resection while initially eligible for transplantation, only 20 (20%) were secondarily transplanted, 17 of whom (17%) for tumor recurrence and 3 (3%) for hepatic decompensation. Transplantability of tumoral recurrence was 25% (17 of 69 recurrences). Compared with primarily transplanted patients, transplantable resected patients had a decreased 5-year overall survival (50% versus 61%; P = 0.05) and disease-free survival (18% versus 58%; P < 0.0001), despite the use of secondary LT.On a multivariate analysis including 271 patients eligible for transplantation and treated by either liver resection or primary LT, liver resection alone (P < 0.0001; risk ratio [RR] = 3.27) or liver resection with secondary LT (P < 0.05; RR= 1.87) emerged as negative independent factors of disease-free survival as compared with primary LT. A number of nodules > 3 (P = 0.002; RR= 2.02) and a maximum tumor size exceeding 30 mm (P < 0.0001; RR=1.93) were also predictive of lower disease-free survival. CONCLUSIONS: LT after liver resection is associated with a higher operative mortality, an increased risk of recurrence, and a poorer outcome than primary LT. In addition, liver resection as a bridge to LT impairs the patient transplantability and the chance of long-term survival of cirrhotic patients with HCC. Primary LT should therefore remain the ideal choice of treatment of a cirrhotic patient with HCC, even when the tumor is resectable. 相似文献
962.
Emmanouil Angelakis Oleg Mediannikov Sarah-Lyne Jos Jean-Michel Berenger Philippe Parola Didier Raoult 《Emerging infectious diseases》2016,22(2):285-288
Bacteria genetically related to Coxiella burnetii have been found in ticks. Using molecular techniques, we detected Coxiella-like bacteria, here named Candidatus Coxiella massiliensis, in skin biopsy samples and ticks removed from patients with an eschar. This organism may be a common agent of scalp eschar and neck lymphadenopathy after tick bite. 相似文献
963.
964.
965.
Maslin J Rogier C Berger F Khamil MA Mattera D Grandadam M Caron M Nicand E 《Journal of acquired immune deficiency syndromes (1999)》2005,39(2):129-132
During a national survey in 2002 in Djibouti, serum samples were collected using a valid sampling scheme from 2423 Djiboutians representing the general population of urban and rural districts. The HIV-1 seroprevalence was 2%. The HIV-1 polymerase gene from 53 untreated patients was amplified. Phylogenetic analysis of 34 isolates revealed a majority of subtype C (73%) as well as other subtypes, including CRF02_AG recombinants (18%), subtype D (6%), and subtype A (3%). 相似文献
966.
967.
Patricia Pavese Agnès Bonadona Jean Beaubien Pascal Labrecque Gilles Pernod Christian Letoublon Didier Barnoud 《Journal canadien d'anesthésie》2005,52(1):26-29
PURPOSE: During liver transplantation, excessive blood losses are correlated with increased morbidity and mortality. Blood losses are particularly high in the case of urgent liver transplantation for fulminant hepatic failure (FHF). Recombinant activated factor VII (rFVIIa) has shown promise in treating the coagulopathy of liver disease. We review our experience with the use of rFVIIa in treating the coagulopathy of FHF during urgent liver transplantation. CLINICAL FEATURES: We report four patients with FHF who met King's College criteria for liver transplantation and in whom rFVIIa was used after conventional means for treating the associated coagulopathy had failed. In all patients, the coagulation defect was corrected by rFVIIa. However, thrombotic complications occurred in two patients (myocardial ischemia and portal vein thrombosis) and the implication of rFVIIa cannot be excluded. CONCLUSION: We conclude that rFVIIa is effective in the correction of the coagulopathy associated with FHF. However, thrombotic events are of concern and therefore, further studies are warranted to define the safety of rFVIIa in that setting. 相似文献
968.
Nicolas Costes Isabelle Merlet Karine Ostrowsky Isabelle Faillenot Franck Lavenne Luc Zimmer Philippe Ryvlin Didier Le Bars 《Journal of nuclear medicine》2005,46(12):1980-1989
Neurotransmission imaging studies require normative data for the statistical assessment of neurophysiologic dysfunctions. 2'-Methoxyphenyl-(N-2'-pyridinyl)-p-18F-fluoro-benzamidoethylpiperazine (18F-MPPF) is a specific serotonin 5-HT1A antagonist PET tracer recently characterized, modeled, and used for clinical research to explore abnormalities in the serotoninergic system. Our study reports, to our knowledge, the first large normative imaging database of 18F-MPPF binding potential (BP) over aging, for both males and females. METHODS: Fifty-three healthy volunteers (27 females, 26 males; age, 20-70 y) were selected to undergo structural MRI and single-injection 18F-MPPF multiframe dynamic PET. 18F-MPPF BP values were computed using a nonlinear modeling method with tissue reference. The statistical assessment of the effect of age and sex was performed both at the anatomic structure level, using regions of interest drawn manually on individual MR images, and at the voxel level, using normalized BP parametric images in different statistical parametric mapping designs. RESULTS: A negative linear correlation between age and 18F-MPPF binding (3.6% decrease by decade) was found in females but not in males and involved most of the limbic and paralimbic regions; on the other hand, males in their 30s showed decreased binding in most cerebral regions. CONCLUSION: A comparison of males and females revealed higher BP values independent of age in females in the right hemisphere and a different evolution of BP over aging. These results confirm the necessity of a database for further statistical analysis in individuals or groups with pathology. 相似文献
969.
Daniel Redoulés Jacques Perie† Cécile Viodé Alain Mavon‡ Didier Fournier§ Sylvie Daunes‡ Christiane Casas reé Lougarre§ Nancy. De Viguerie† 《Journal of general internal medicine》2005,20(5):270-277
A new strategy for the skin delivery of bioactive compounds has been developed, using enzymes involved in the maintenance of the epidermal barrier function and the enzymatic transformation of corresponding precursors. This new strategy has been tested with regard to two enzymatic activities of the skin barrier: extracellular glucosidase and esterase/lipase. An analysis of the requirements for the glycosidic bond hydrolysis of any glycoconjugate by β-glucocerebrosidase indicates that the release of the moiety linked to the glucose unit is obtained as long as the glycosidic bond being broken is not hindered, and as long as the leaving group property of the released moiety is good enough. This strategy was first applied to the release of the antioxidant δ-tocopherol. It was then extended to retinoic acid by introducing a spacer between the glucose unit and the bioactive moiety. This spacer was either a good leaving group such as hydroquinone, or a structure akin to a ceramide, namely glycerol. In these conditions, β-glucocerebrosidase releases the complex spacer-active compound that is cleaved by an esterase. One of the advantages of this strategy lies in the slow release of the bioactive compound, extending in time its effect and most likely its tolerance, as is the case for retinoic acid. 相似文献
970.